Photo: © Unknown.

COVID-19 Vaccine Approval Study in Argentina: How Pfizer-BioNTech Suppressed Evidence About Vaccination Damage, Deaths

How many serious side effects, how many deaths have there really been in Pfizer’s studies to approve its BioNTech COVID-19 vaccine? Much of Pfizer’s studies to approve the BioNTech vaccine took place in Argentina, which became one the largest clinical trial sites for the pharmaceutical company, with almost 6,000 of the 43,548 subjects worldwide.

There are now reports that Pfizer intentionally concealed major irregularities with serious consequences in its vaccine approval study in Argentina. This includes cases of serious vaccination damage and in some cases, deaths.
What did those cases suggest that Pfizer did not want to be shown in the approval study? Would the inclusion of such information have prevented the approval of Pfizer’s BioNTech COVID-19 vaccine, which the company knew was practically guaranteed by governments because of a perceived public health emergency? What role did this perception of a health emergency play in the vaccine approval, and to what extent was was this perception based on the actual risks posed by the virus?

Internal documents show governments had de facto signalled to Pfizer they were already inclined to approve its vaccine even before they could assess the approval study results. E-mails from the European Medicines Agency (EMA), which are available to Welt, show that the U.S Federal Drug Administration (FDA), the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) and the EMA itself had already agreed on the date of approval before they could even take a look at the Pfizer papers. Were governments really able to conduct a proper assessment of Pfizer’s approval study? Was the approval of the vaccine based on its actual safety or other considerations?

Patient Number 12312982: Augusto Roux

Take the case of Augusto Roux, a 36-year old lawyer from Buenos Aires, Argentina, who participated in the third, decisive test phase for the mRNA BioNTech/Pfizer vaccine approval study. With Roux as with several other cases in that Pfizer approval study, many things did not go as they should. But these do no appear in Pfizer’s approval study. What was the company concerned about?

The vaccination damage experienced by Augusto Roux, registered as patient Number 12312982, is impressive. After the first injection in August 2020, he suffered swelling in his arm, nausea and difficulty swallowing, later a kind of hangover, a change in his sense of smell, his stools turned white and his urine dark. After two days, doctors noted an “undesirable effect of toxicity grade 1”. When he received the second dose three weeks later, Roux initially felt fine, but felt unwell on the way home and later developed shortness of breath, burning chest pain, nausea and fever. His urine was black and Roux passed out, being taken to the hospital where no Covid was found. Sick, Roux withdrew from the study. His discharge report states that he had “Adverse reaction to the coronavirus vaccine (high probability).”

In reality, Roux had pericarditis, an inflammation of the pericardium. He also had liver inflammation.

Augusto Roux, the 36-year old Argentian lawyer, who participated in the Pfizer/BioNTech vaccine approval study in Argentina.

What is interesting about the Roux case is how Pfizer recorded his vaccination experience. The pharmaceutical company’s papers say Roux apparently told the researchers that after the first dose he had had pneumonia on both sides, following the initial report, which was classified as an Adverse Reaction of Toxicity Level 1. The file further states this has nothing to do with the vaccine and is probably due to a COVID infection.

But none of this was true: Roux did not have pneumonia and had also tested negative for Corona in several PCR tests.

Roux’s file at Pfizer also mentions he had a “severe anxiety attack” after the second dose. But while Roux does suffer from anxiety, it is not due to the vaccine.

Why was Roux’s case being recorded in this way? Was it an attempt to reinterpret his case from one of vaccination damage to a problem of mental health?

But it gets stranger. Augusto Roux is completely omitted in the Pfizer study that was finally published in December 2020. In a summary of all study data for the US Food and Drug Administration as of August 11, 2021, only one case of pericarditis was recorded among the vaccinated subjects, and it is about a man older than 55. How could Pfizer not mention Roux, when he too suffered from pericarditis after taking the vaccine? How did Pfizer classify the Roux case, so that it would not have include the effects experienced by the young man after vaccination? Was he registered as a COVID-19 case, so that he could be counted as unvaccinated?

According to John Guetzkow, who writes regularly about the adverse effects of the vaccine and the major irregularities surrounding the circumstances in which the COVID-19 vaccine was approved, the disappeared case of Augusto Roux in the final vaccine approval study could be the key to “proving Pfizer vaccine trial fraud”.

More Skeletons

The irregularities do not stop with Roux. During the approval study, the Buenos Aires test center lost 53 subjects in one go on August 31, 2020. The stated reason is that the test candidates were “unblinded”, which means they were informed about their vaccination status. Again, this is not mentioned in the study. What could have happened? One speculation is that the 53 subjects reported serious adverse effects due to the vaccine, given that they knew they had received the vaccine and they could thus know where their symptoms could be coming from. attribute the effects they experienced to the injection. According to David Healy, professor of psychiatry and phamacologist, Pfizer gave “three different explanations for the exclusion of the 53 subjects in three different documents,”:

“One document notes that all participants received the standard dose at the correct time, a second states that there was an error in the dose for all, and the third mentions irregularities for all but does not say which.”

There were more omissions. One man was in the placebo group and died of a heart attack during the study. The case was initially kept secret from the Argentine authority ANMAT, only to reappear in the approval study.

In addition, there were 21 deaths in the “vaccine group” who had received the mRNA preparation from BioNTech-Pfizer. According to the study authors, these deaths are not due to the “vaccine.” However, one of the patients – no. 11621327 – was found dead at his home three days after his second dose, dying of a stroke. Another – patient 11521497 – died of cardiac arrest 20 days after the “vaccination”.

Pfizer also claims its mRNA vaccine is safe for adolescents. According to the approval study the company published on the subject, the vaccine “shows a favorable safety profile” in 12- to 15-year-olds and that there were “no serious vaccine-related events” among the participants. In the appendices at the end, under “serious events,” the number is 4. Of these, 0 are vaccine-related. One of the four is 13-year-old Maddie de Garay, daughter of Stephanie de Garay.

Within hours of receiving the second dose in early January 2021, Maddie experienced “zapping pain up and down her spine with severe abdominal pain… her toes and fingers turned white and were ice cold”. She can now barely see, has at least 10-20 seizures a day and stays in a wheelchair. She is fed through a nasogastric tube. Yet her injury was recorded in the vaccine trial data as “abdominal pain” and claimed without evidence to be not related to the vaccine.

What Next?

Since October 2022, the Argentine parliament has set up a committee of inquiry into the irregularities of the Pfizer studies in Argentina. No answers have been provided yet. The suspicion is that that there have been other deaths or side effects that Pfizer kept secret.

Legally, however, Pfizer has stacked the odds in its favor. Pfizer’s vaccine contract with the Argentinian government states the pharmaceutical company does not guarantee anything with its vaccine. A liability waiver was also signed even in case of negligence and “fraud or bad faith on the part of Pfizer itself.”

In 2022, Özlem Türeci and Ugur Sahin, the founders of BioNTech who developed the Pfizer/BioNTech COVID-19 vaccine, received one of Germany’s highest honors – the Grand Cross of Merit with Star of the Order of Merit of the Federal Republic of Germany – for contributing to the “containment of the coronavirus pandemic.”

The founders of the pharmaceutical company BioNTech and developers of the BioNTech/Pfizer vaccine, Ugur Sahin & Özlem Türeci, receive the Order of Merit of the Federal Republic of Germany by President Frank-Walter Steinmeier & Chancellor Angela Merkel on March 19, 2021.
Did you experience vaccination damage after taking the COVID-19 vaccine? What were your sources of information about the vaccine’s safety and what role did they play in determining your decision to take the vaccine? TCE wants to know. Write to
Leave a Reply